- ‘Nipple-Sparing’ Mastectomies Don’t Raise Odds of Cancer’s Return: Study
- Early Menopause May Be Tied to Type 2 Diabetes
- Most Women Should Forgo Ovarian Cancer Screening: Panel
- Women Driven to Be Thinner When Husband Is Hot
- Few Patients Receive Rx for Smoking Cessation Meds After MI
- ‘Expansion Pathology’ Method Could Mean Earlier Intervention
- Educational Intervention Doesn’t Up Hand, Stethoscope Hygiene
Elizabeth M. Swisher, MD. Dr. Elizabeth M. Swisher comments on the implications of new data from the ARIEL2 trial, an ongoing Phase 2 trial of the novel PARP inhibitor rucaparib in relapsed, high-grade serous or endometrioid ovarian cancer. The new results offer an important insight into the genetic mechanisms behind tumor sensitivity… Dr. Alberto De la Guerra. The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision.
Debbie Miller, RN. Prior to the introduction of the medical community in the natural birth process, any maternal recommendations and guidelines were passed from mother to daughter or through lay midwives, herbal and folk practitioners. Childbirth, though risky, was not considered pathological and the majority did not receive…
The BRCA gene test is used to identify mutations in either one of the two breast cancer susceptibility genes, BRCA1 and BRCA2. Women who have inherited…
Thank you for reading my article. Interesting theory. Lots of research is ongoing to figure out the many ways aspirin does it magic.
Times Online / The Sunday Times voted Doctors Lounge as 3rd best ‘Ask an expert’ website.